1. Home
  2. ABEO
  3. ABEO News

Latest Abeona Therapeutics Inc. (ABEO) News on July 2, 2025

Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa
ABEO

GlobeNewswire

8 days ago

Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

a month ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference
ABEO

GlobeNewswire

a month ago

Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference

ABEO

Zacks Small Cap Research

a month ago

ABEO: Sells Priority Review Voucher for $155 Million…

ABEO

Associated Press Finance

2 months ago

Abeona Therapeutics: Q1 Earnings Snapshot

Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates
ABEO

GlobeNewswire

2 months ago

Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates

UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder
ABEO

GlobeNewswire

2 months ago

UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder

Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder
ABEO

GlobeNewswire

2 months ago

Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder

Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder
ABEO

GlobeNewswire

2 months ago

Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder

Abeona secures cash runway with $155m priority review voucher sale
ABEO

Pharmaceutical Technology

2 months ago

Abeona secures cash runway with $155m priority review voucher sale

ABEO

MT Newswires

2 months ago

Abeona Therapeutics to Sell Zevaskyn Priority Review Voucher for $155 Million; Shares Rise

Abeona Therapeutics® Enters into Agreement to Sell Priority Review Voucher for $155 Million
ABEO

GlobeNewswire

2 months ago

Abeona Therapeutics® Enters into Agreement to Sell Priority Review Voucher for $155 Million

Abeona sells speedy drug review voucher for $155M
ABEO

BioPharma Dive

2 months ago

Abeona sells speedy drug review voucher for $155M

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

2 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FDA approves Abeona’s $3.1m cell therapy for rare skin disease
ABEO

Pharmaceutical Technology

2 months ago

FDA approves Abeona’s $3.1m cell therapy for rare skin disease

ABEO

Zacks Small Cap Research

2 months ago

ABEO: Zevaskyn™ Approved by FDA; Raising Valuation to $11…

Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy
ABEO

Benzinga

2 months ago

Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy

ABEO

MT Newswires

2 months ago

Abeona Therapeutics Says US FDA Approves Zevaskyn to Treat Wounds in Patients With Genetic Skin Disease

U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)
ABEO

GlobeNewswire

2 months ago

U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

3 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO

Zacks Small Cap Research

3 months ago

ABEO: Countdown to PDUFA Date of April 29, 2025…

Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...
ABEO

GuruFocus.com

3 months ago

Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...

ABEO

Thomson Reuters StreetEvents

3 months ago

Q4 2024 Abeona Therapeutics Inc Earnings Call

Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans
ABEO

GlobeNewswire

3 months ago

Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans

Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference
ABEO

GlobeNewswire

4 months ago

Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference

Abeona Therapeutics announces new employee inducement grants
ABEO

TipRanks

4 months ago

Abeona Therapeutics announces new employee inducement grants

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

4 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics Inc.'s (NASDAQ:ABEO) Shift From Loss To Profit
ABEO

Simply Wall St.

5 months ago

Abeona Therapeutics Inc.'s (NASDAQ:ABEO) Shift From Loss To Profit

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

5 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

6 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Owning 43% shares,institutional owners seem interested in Abeona Therapeutics Inc. (NASDAQ:ABEO),
ABEO

Simply Wall St.

6 months ago

Owning 43% shares,institutional owners seem interested in Abeona Therapeutics Inc. (NASDAQ:ABEO),

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

7 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO

ACCESSWIRE

7 months ago

DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

ABEO

Zacks Small Cap Research

7 months ago

ABEO: FDA Accepts BLA Re-Submission for Pz-cel; PDUFA Date of April 29, 2025; Raising Valuation to $9.50…

Abeona Therapeutics Inc (ABEO) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
ABEO

GuruFocus.com

8 months ago

Abeona Therapeutics Inc (ABEO) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

ABEO

Associated Press Finance

8 months ago

Abeona Therapeutics: Q3 Earnings Snapshot

Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
ABEO

GlobeNewswire

8 months ago

Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
ABEO

GlobeNewswire

8 months ago

Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa

Abeona Therapeutics® Announces Participation in November Investor Conferences
ABEO

GlobeNewswire

8 months ago

Abeona Therapeutics® Announces Participation in November Investor Conferences

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

8 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
ABEO

GlobeNewswire

8 months ago

Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration

Abeona Therapeutics Inc (ABEO) Q2 2024 Earnings Call Highlights: Strong Financial Performance ...
ABEO

GuruFocus.com

9 months ago

Abeona Therapeutics Inc (ABEO) Q2 2024 Earnings Call Highlights: Strong Financial Performance ...

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

9 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
ABEO

GlobeNewswire

10 months ago

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

10 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO

Zacks Small Cap Research

a year ago

ABEO: Type A Meeting with FDA Concluded; BLA Submission on Track for 2H24…

Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors

Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel

ABEO

MT Newswires

a year ago

Abeona Therapeutics Shares Jump After Q2 Loss Narrows

ABEO

Associated Press Finance

a year ago

Abeona Therapeutics: Q2 Earnings Snapshot

Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Institutional investors own a significant stake of 39% in Abeona Therapeutics Inc. (NASDAQ:ABEO)
ABEO

Simply Wall St.

a year ago

Institutional investors own a significant stake of 39% in Abeona Therapeutics Inc. (NASDAQ:ABEO)

ABEO

MT Newswires

a year ago

Abeona Therapeutics Partners with Beacon Therapeutics to Develop Ophthalmic Gene Therapies

Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications

Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum

Insider Sale: Director Christine Silverstein Sells Shares of Abeona Therapeutics Inc (ABEO)
ABEO

GuruFocus.com

a year ago

Insider Sale: Director Christine Silverstein Sells Shares of Abeona Therapeutics Inc (ABEO)

ABEO

MT Newswires

a year ago

Abeona Therapeutics Files for $300 Million Mixed Shelf, $75 Million At-The-Market Offering

ABEO

Business Wire

a year ago

Net Asset Value(s)

Irish, Czechs hold EU vote after Dutch far-right gains
ABEO

AFP

a year ago

Irish, Czechs hold EU vote after Dutch far-right gains

Trade the Nvidia Stock Split? The Tried-and-True Method to Make the Best Profits on the Leading AI Stock
ABEO

Motley Fool

a year ago

Trade the Nvidia Stock Split? The Tried-and-True Method to Make the Best Profits on the Leading AI Stock

GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials
ABEO

GlobeNewswire

a year ago

GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials

[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
ABEO

GlobeNewswire

a year ago

[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Pioneering Progress, Shaping Tomorrow: SUPCON Global Product Launch Conference 2024 Held in Singapore
ABEO

PR Newswire

a year ago

Pioneering Progress, Shaping Tomorrow: SUPCON Global Product Launch Conference 2024 Held in Singapore

Bitcoin ReoPro 3.0 Transforms Trading with AI Innovation
ABEO

PR Newswire

a year ago

Bitcoin ReoPro 3.0 Transforms Trading with AI Innovation

3 Major Product Releases at 3Shape Discover Event
ABEO

PR Newswire

a year ago

3 Major Product Releases at 3Shape Discover Event

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO

MT Newswires

a year ago

Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target

Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference

ABEO

Zacks Small Cap Research

a year ago

ABEO: BLA Resubmission in 2H24

ABEO

GuruFocus.com

a year ago

Abeona Therapeutics Inc (ABEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...

ABEO

Thomson Reuters StreetEvents

a year ago

Q1 2024 Abeona Therapeutics Inc Earnings Call

ABEO

Associated Press Finance

a year ago

Abeona Therapeutics: Q1 Earnings Snapshot

Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO

MT Newswires

a year ago

Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise

Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

ABEO

Zacks Small Cap Research

a year ago

ABEO: Receives CRL Based on Need for More CMC Information…

ABEO

MT Newswires

a year ago

Top Midday Decliners

ABEO

MT Newswires

a year ago

Top Premarket Decliners

FDA rejects Abeona cell therapy, asks for more manufacturing data
ABEO

BioPharma Dive

a year ago

FDA rejects Abeona cell therapy, asks for more manufacturing data

ABEO

MT Newswires

a year ago

Abeona Therapeutics Shares Slump After Plans to Reapply for Pz-cel Drug Approval

ABEO

Reuters

a year ago

UPDATE 1-US FDA declines to approve Abeona's skin disorder treatment

ABEO

Reuters

a year ago

US FDA declines to approve Abeona's skin disorder treatment

Abeona Therapeutics Provides Regulatory Update on Pz-cel
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Provides Regulatory Update on Pz-cel

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Here's Why We're Not Too Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation
ABEO

Simply Wall St.

a year ago

Here's Why We're Not Too Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation

Abeona Therapeutics Inc (ABEO) Reports Full Year 2023 Financial Results
ABEO

GuruFocus.com

a year ago

Abeona Therapeutics Inc (ABEO) Reports Full Year 2023 Financial Results

Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections

Several Insiders Invested In Abeona Therapeutics Flagging Positive News
ABEO

Simply Wall St.

a year ago

Several Insiders Invested In Abeona Therapeutics Flagging Positive News

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Steven Cohen's Firm Increases Stake in Abeona Therapeutics Inc
ABEO

GuruFocus.com

a year ago

Steven Cohen's Firm Increases Stake in Abeona Therapeutics Inc

Individual investors in Abeona Therapeutics Inc. (NASDAQ:ABEO) are its biggest bettors, and their bets paid off as stock gained 45% last week
ABEO

Simply Wall St.

a year ago

Individual investors in Abeona Therapeutics Inc. (NASDAQ:ABEO) are its biggest bettors, and their bets paid off as stock gained 45% last week

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO

Zacks Small Cap Research

a year ago

ABEO: FDA BIMO Inspection and BLA Mid-Cycle Review Complete…

Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)

Arbe Chipset Empowers HiRain's LRR610 4D Imaging Radar Systems Set for Mass Production by the End of 2024
ABEO

PR Newswire

a year ago

Arbe Chipset Empowers HiRain's LRR610 4D Imaging Radar Systems Set for Mass Production by the End of 2024

Old Second Bancorp, Inc. Reports Fourth Quarter 2023 Net Income of $18.2 Million, or $0.40 per Diluted Share
ABEO

ACCESSWIRE

a year ago

Old Second Bancorp, Inc. Reports Fourth Quarter 2023 Net Income of $18.2 Million, or $0.40 per Diluted Share

Ramaco Hires Director of Critical Minerals and Planning to Oversee Company's Rare Earth Element Development
ABEO

PR Newswire

a year ago

Ramaco Hires Director of Critical Minerals and Planning to Oversee Company's Rare Earth Element Development

Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board
ABEO

GlobeNewswire

a year ago

Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board

Share on Social Networks: